Unknown

Dataset Information

0

Active-Site Conformational Fluctuations Promote the Enzymatic Activity of NDM-1.


ABSTRACT: ?-Lactam antibiotics are the mainstay for the treatment of bacterial infections. However, elevated resistance to these antibiotics mediated by metallo-?-lactamases (MBLs) has become a global concern. New Delhi metallo-?-lactamase-1 (NDM-1), a newly added member of the MBL family that can hydrolyze almost all ?-lactam antibiotics, has rapidly spread all over the world and poses serious clinical threats. Broad-spectrum and mechanism-based inhibitors against all MBLs are highly desired, but the differential mechanisms of MBLs toward different antibiotics pose a great challenge. To facilitate the design of mechanism-based inhibitors, we investigated the active-site conformational changes of NDM-1 through the determination of a series of 15 high-resolution crystal structures in native form and in complex with products and by using biochemical and biophysical studies, site-directed mutagenesis, and molecular dynamics computation. The structural studies reveal the consistency of the active-site conformations in NDM-1/product complexes and the fluctuation in native NDM-1 structures. The enzymatic measurements indicate a correlation between enzymatic activity and the active-site fluctuation, with more fluctuation favoring higher activity. This correlation is further validated by structural and enzymatic studies of the Q123G mutant. Our combinational studies suggest that active-site conformational fluctuation promotes the enzymatic activity of NDM-1, which may guide further mechanism studies and inhibitor design.

SUBMITTER: Zhang H 

PROVIDER: S-EPMC6201099 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Active-Site Conformational Fluctuations Promote the Enzymatic Activity of NDM-1.

Zhang Hongmin H   Ma Guixing G   Zhu Yifan Y   Zeng Lingxiao L   Ahmad Ashfaq A   Wang Changzhi C   Pang Bo B   Fang Huiyan H   Zhao Liqing L   Hao Quan Q  

Antimicrobial agents and chemotherapy 20181024 11


β-Lactam antibiotics are the mainstay for the treatment of bacterial infections. However, elevated resistance to these antibiotics mediated by metallo-β-lactamases (MBLs) has become a global concern. New Delhi metallo-β-lactamase-1 (NDM-1), a newly added member of the MBL family that can hydrolyze almost all β-lactam antibiotics, has rapidly spread all over the world and poses serious clinical threats. Broad-spectrum and mechanism-based inhibitors against all MBLs are highly desired, but the dif  ...[more]

Similar Datasets

| S-EPMC5026167 | biostudies-literature
| S-EPMC4680847 | biostudies-literature
| S-EPMC10245850 | biostudies-literature
| S-EPMC518831 | biostudies-literature
| S-EPMC2629113 | biostudies-literature
| S-EPMC9900621 | biostudies-literature
| S-EPMC5293602 | biostudies-literature
| S-EPMC3264664 | biostudies-literature
| S-EPMC2939078 | biostudies-literature
| S-EPMC556001 | biostudies-literature